Impact of androgens, growth hormone, and IGF-I on bone and muscle in male mice during puberty
- PMID: 17014385
- DOI: 10.1359/jbmr.060911
Impact of androgens, growth hormone, and IGF-I on bone and muscle in male mice during puberty
Abstract
The interaction between androgens and GH/IGF-I was studied in male GHR gene disrupted or GHRKO and WT mice during puberty. Androgens stimulate trabecular and cortical bone modeling and increase muscle mass even in the absence of a functional GHR. GHR activation seems to be the main determinant of radial bone expansion, although GH and androgens are both necessary for optimal stimulation of periosteal growth during puberty.
Introduction: Growth hormone (GH) is considered to be a major regulator of postnatal skeletal growth, whereas androgens are considered to be a key regulator of male periosteal bone expansion. Moreover, both androgens and GH are essential for the increase in muscle mass during male puberty. Deficiency or resistance to either GH or androgens impairs bone modeling and decreases muscle mass. The aim of the study was to investigate androgen action on bone and muscle during puberty in the presence and absence of a functional GH/insulin-like growth factor (IGF)-I axis.
Materials and methods: Dihydrotestosterone (DHT) or testosterone (T) were administered to orchidectomized (ORX) male GH receptor gene knockout (GHRKO) and corresponding wildtype (WT) mice during late puberty (6-10 weeks of age). Trabecular and cortical bone modeling, cortical strength, body composition, IGF-I in serum, and its expression in liver, muscle, and bone were studied by histomorphometry, pQCT, DXA, radioimmunoassay and RT-PCR, respectively.
Results: GH receptor (GHR) inactivation and low serum IGF-I did not affect trabecular bone modeling, because trabecular BMD, bone volume, number, width, and bone turnover were similar in GHRKO and WT mice. The normal trabecular phenotype in GHRKO mice was paralleled by a normal expression of skeletal IGF-I mRNA. ORX decreased trabecular bone volume significantly and to a similar extent in GHRKO and WT mice, whereas DHT and T administration fully prevented trabecular bone loss. Moreover, DHT and T stimulated periosteal bone formation, not only in WT (+100% and +100%, respectively, versus ORX + vehicle [V]; p < 0.05), but also in GHRKO mice (+58% and +89%, respectively, versus ORX + V; p < 0.05), initially characterized by very low periosteal growth. This stimulatory action on periosteal bone resulted in an increase in cortical thickness and occurred without any treatment effect on serum IGF-I or skeletal IGF-I expression. GHRKO mice also had reduced lean body mass and quadriceps muscle weight, along with significantly decreased IGF-I mRNA expression in quadriceps muscle. DHT and T equally stimulated muscle mass in GHRKO and WT mice, without any effect on muscle IGF-I expression.
Conclusions: Androgens stimulate trabecular and cortical bone modeling and increase muscle weight independently from either systemic or local IGF-I production. GHR activation seems to be the main determinant of radial bone expansion, although GHR signaling and androgens are both necessary for optimal stimulation of periosteal growth during puberty.
Similar articles
-
Growth without growth hormone receptor: estradiol is a major growth hormone-independent regulator of hepatic IGF-I synthesis.J Bone Miner Res. 2005 Dec;20(12):2138-49. doi: 10.1359/JBMR.050811. Epub 2005 Aug 8. J Bone Miner Res. 2005. PMID: 16294267
-
Relative impact of androgen and estrogen receptor activation in the effects of androgens on trabecular and cortical bone in growing male mice: a study in the androgen receptor knockout mouse model.J Bone Miner Res. 2006 Apr;21(4):576-85. doi: 10.1359/jbmr.060103. Epub 2006 Apr 5. J Bone Miner Res. 2006. PMID: 16598378
-
Role of the androgen receptor in skeletal homeostasis: the androgen-resistant testicular feminized male mouse model.J Bone Miner Res. 2004 Sep;19(9):1462-70. doi: 10.1359/JBMR.040505. Epub 2004 May 10. J Bone Miner Res. 2004. PMID: 15312246
-
Sex steroids, growth hormone, insulin-like growth factor-1: neuroendocrine and metabolic regulation in puberty.Horm Res. 1996;45(1-2):74-80. doi: 10.1159/000184763. Horm Res. 1996. PMID: 8742123 Review.
-
Disruption of the GH receptor gene in adult mice and in insulin sensitive tissues.Growth Horm IGF Res. 2018 Feb;38:3-7. doi: 10.1016/j.ghir.2017.11.003. Epub 2017 Nov 24. Growth Horm IGF Res. 2018. PMID: 29198419 Review.
Cited by
-
The role of GH/IGF-I-mediated mechanisms in sex differences in cortical bone size in mice.Calcif Tissue Int. 2011 Jan;88(1):1-8. doi: 10.1007/s00223-010-9436-2. Epub 2010 Nov 27. Calcif Tissue Int. 2011. PMID: 21113585 Free PMC article. Review.
-
Role of the GH/IGF-1 axis in lifespan and healthspan: lessons from animal models.Growth Horm IGF Res. 2008 Dec;18(6):455-71. doi: 10.1016/j.ghir.2008.05.005. Epub 2008 Aug 16. Growth Horm IGF Res. 2008. PMID: 18710818 Free PMC article. Review.
-
Sarcopenia in Children with Solid Organ Tumors: An Instrumental Era.Cells. 2022 Apr 9;11(8):1278. doi: 10.3390/cells11081278. Cells. 2022. PMID: 35455957 Free PMC article. Review.
-
Age-related changes in densitometry and histomorphometry of long bone during the pubertal growth spurt in male rats.Anat Sci Int. 2024 Jun;99(3):268-277. doi: 10.1007/s12565-024-00766-6. Epub 2024 Apr 10. Anat Sci Int. 2024. PMID: 38598056
-
Muscle-Bone Crosstalk: Emerging Opportunities for Novel Therapeutic Approaches to Treat Musculoskeletal Pathologies.Biomedicines. 2017 Oct 24;5(4):62. doi: 10.3390/biomedicines5040062. Biomedicines. 2017. PMID: 29064421 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases